Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Interview: Enhancing Clinical Trials with CliniPilot and Clear to Clinic Programme

In this exclusive interview, Dr Carolina Canapè and Roger Lüscher talk with ONdrugDelivery’s Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors …

The compass for innovation: Regulatory Affairs at Ypsomed

Acting as the compass for innovation, Ypsomed’s regulatory strategy steers ideas through development to deliver safe, compliant solutions to patients worldwide.

Self-injection device manufacturing in a dynamic world

How did pen-inspired injectors evolve into today’s flexible self-injection platforms? Discover the trends in usability, scale-up, and resilient manufacturing that are shaping the future of drug delivery in a fast-changing industry landscape.

Sustainable GLP-1 drug delivery

GLP-1 therapies are entering a high-growth phase, driving demand for scalable, sustainable delivery solutions. As formulations evolve, device usability, and environmental impact becomes a key industry challenge.

Automated assembly for fast-track design verification of YpsoMate platforms

Discover how Ypsomed’s innovative in-house assembly system streamlines workflows, enhances precision and slashes verification times, helping customers bring their products to market with speed and confidence.

High performance in high-dose drug delivery

Discover how Ypsomed’s advanced delivery devices, including YpsoMate and YpsoDose, empower high-dose drug delivery. From viscosities to volumes, our innovative platforms transform patient care and enable pharmaceutical success. Explore the solutions …

Subcutaneous drug delivery: Adapting to high-viscosity, large-volume demands

Explore how Ypsomed is innovating subcutaneous drug delivery to meet the demands of high-viscosity and large-volume formulations.

Ypsomed’s platform product transformation and approach to strategic partner networking

​Over the last 40 years, we have been at the forefront of the development and manufacturing of self-injection systems. How has Ypsomed transformed the market for platform-based self-injection devices?

First Deliveries of YpsoMate 1 mL as part of the NetZero Program

Ypsomed supplied first batches of YpsoMate 1 mL with a reduced carbon footprint as part of the NetZero Program in 2023 . This milestone is a key step in the transformation of the platform proven YpsoMate autoinjector into a zero-carbon emission …
Load more